Advanced radiant oncology
نویسندگان
چکیده
منابع مشابه
Roles of advanced practice nurses in oncology.
Managed care is a process of health-care management that integrates financing, cost-containment strategies, and business principles with the delivery of health care. Managed care's rapid transformation of specialty practices, such as oncology, is redirecting classic nursing functions toward market initiatives that value the design of care/case management systems and the implementation of multid...
متن کاملRoles of Advanced Practice Nurses in Oncology
The once identifiable hallmarks of the American entrepreneurial health-care systemaccess to care on demand, unrestricted provider choice, and a relatively stable delivery systemhave been supplanted by a process of health-care management commonly referred to as managed care. In the broadest sense, managed care can be defined as a variety of methods to finance and organize the delivery of compr...
متن کاملDynamic VIEWS, InterVIEWS, RADIANT and Tim: Advanced MR Techniques for Breast Cancer Imaging
In the early 1990‘s initial clinical applications of magnetic resonance imaging of the breast, relied either on a series of low-resolution dynamic (kinetic) images or longer, high-resolution (morphologic) images to differentiate benign from malignant processes. Current MR equipment, however, allows a hybrid technique, providing both kinetic data and high-resolution morphologic information in on...
متن کاملRadiant distribution of micrometeors
Precise knowledge of the angle between the meteor vector velocity and the radar beam axis is one of the largest source of errors in the Arecibo Observatory (AO) microme-teor observations. In this paper we study ∼250 high signal-to-noise ratio (SNR) meteor head-echoes obtained using the dual-beam 430 MHz AO Radar in Puerto Rico, in or-5 der to reveal the distribution of this angle. All of these ...
متن کاملEverolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis
In the phase III RADIANT-4 study, everolimus improved median progression-free survival (PFS) by 7.1 months in patients with advanced, progressive, well-differentiated (grade 1 or grade 2), non-functional lung or gastrointestinal neuroendocrine tumors (NETs) vs placebo (hazard ratio, 0.48; 95% confidence interval [CI], 0.35-0.67; P < .00001). This exploratory analysis reports the outcomes of the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anales de la Facultad de Ciencias Médicas (Asunción)
سال: 2019
ISSN: 1816-8949,2313-2841
DOI: 10.18004/anales/2019.052(02)13-016